BioSpace News Archive

Business

Dr. R. Lawrence Moss Begins Tenure As President, CEO Of Nemours Children’s Health System

Succeeds Dr. David Bailey As Leader of Nationally Recognized Pediatric System

October 1, 2018
·
4 min read
Policy

New Social Campaign Urges California Voters to Vote NO on Prop 8

The ballot initiative is dangerous for kidney patients and could result in cuts in their care

October 1, 2018
·
4 min read
Business

Decision Resources Group Appoints Michael Weiss As Executive Vice President and General Counsel

Decision Resources Group (DRG), a premier provider of healthcare data, analytics, and insights products and services, announced that Michael Weiss has been named Executive Vice President and General Counsel, effective October 1.

October 1, 2018
·
1 min read
FDA

FDA Approves KYPROLIS® (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone (Kd70) For Patients With Relapsed Or Refractory Multiple Myeloma

Approval of a More Convenient Once-Weekly Kd70 Regimen Based on Data From Phase 3 Head-to-Head A.R.R.O.W. Study

October 1, 2018
·
19 min read
Business

Fundamental Advisors and Senior Care Development Form Joint Venture to Acquire Skilled Nursing Assets

JV Intends to Acquire up to $1 Billion in Skilled Nursing Assets

October 1, 2018
·
3 min read
Policy

Intertek Prepares to Support Industry as New Guidance Documents for the Notification and Testing of New Substances Are Published

Intertek prepares to support the implementation of the revised Guidelines for the ‘Notification and Testing of New Substances: Chemicals and Polymers’ to be issued by the Government of Canada.

October 1, 2018
·
2 min read
Deals

Altasciences Completes Acquisition of Preclinical Testing Business and Hires Key Staff

This transaction will support Altasciences’ goal of being a mid-sized CRO that will provide talent and scale to support the preclinical and clinical markets while creating a new outsourcing paradigm for its clients.

October 1, 2018
·
2 min read
BioForest

Achieve Announces Pricing of $5.6 Million Registered Direct Offering

Achive has entered into a securities purchase agreement with certain institutional investors providing for the purchase and sale of 1,789,258 shares of common stock at a price of $3.1445 per share in a registered direct offering, resulting in total gross proceeds of approximately $5.6 million.

October 1, 2018
·
5 min read
Business

Syneron Candela Announces Launch of Direct Operation in Korea

Syneron Candela Korea Co. Ltd focused on enhancing Customer Service in Growth Markets

October 1, 2018
·
2 min read
Policy

DaVita Responds to Senate Bill 1156 Veto

DaVita Kidney Care is a division of DaVita Inc., a Fortune 500® company, that through its operating divisions provides a variety of health care services to patient populations throughout the United States and abroad

October 1, 2018
·
1 min read